| Publication date | Communities | Collections | Article title | Author(s) | Journal/Conference |
|---|---|---|---|---|---|
| 19 Jul 2018 | BMRC | p53 Laboratory | The MDM2/MDMX-p53 Antagonist PM2 Radiosensitizes Wild-Type p53 Tumors | Diana Spiegelberg, Anja C. Mortensen, Sara Lundsten, Christopher J. Brown, David P. Lane, Marika Nestor | Cancer Research |